Lithium toxicity following frusemide administration is reported.
The clinical features, possible causative mechanisms, and management of the intoxication are discussed.
References
1.
BirchN. J. (1975): “Lithium and Magnesium–Dependent Processes”, Lancet, 1, 1384.
2.
BurrowsG. D. (1976): “Psychotherapeutic Drugs: How to Minimize Complications of Therapy”, Current Therapeutics, 17, 49.
3.
CarmelietE. E. (1964): “Influence of Lithium Ions on the Transmembrane Potential and Cation Content of Cardiac Cells”, J. General Physiol., 47, 501.
4.
CohenW. J., and CohenN. H. (1974): “Lithium Carbonate, Haloperidol, and Irreversible Brain Damage”, J. Amer. Med. Ass., 230, 1283.
5.
EmersonC. H., DysonW. L., and UtigerR. D. (1973): “Serum Thyrotropin and Thyroxine Concentrations in Patients Receiving Lithium Carbonate”, J. Clin. Endocrinol. Metab., 36, 338.
6.
EssmanW. B. (1975): “Lithium”, Lancet, 2, 547.
7.
GiocobiniE. (1969): “The Effect of Lithium on the Nerve Cell”, Acta Psychiatr. Scand.207 (Suppl. 45), 85.
8.
GoodmanL. S., and GilmanA. (1970): The Pharmacological Basis of Therapeutics, 4th ed. MacMillan, New York, pp. 193–194.
9.
HerreroF. A. (1973): “Lithium Carbonate Toxicity”, J. Amer. Med. Ass., 226, 1109.
10.
JamesR. J., and DarkenR. A. (1976): “Lithium Carbonate and Hypothyroidism”, Med. J. Aust., 1, 260.
11.
KeynesK. D., and SwanR. C. (1959): “The Permeability of Frog Muscle Fibres to Lithium Ions”, Physiology, 147, 626.
12.
MeyersF. H., JawetzE., and GoldfienA. (1974): Review of Medical Pharmacology, 4th ed. Lange, California, pp. 245–257.
13.
ProckopL. D., and MarcusD. J. (1972): “Cerebrospinal Fluid Lithium: Passive Transfer Kinetics”, Life Sci., 1, 859.
14.
ThomsonK., and SchouM. (1908): “Renal Lithium Excretion in Man”, Amer. J. Physiol., 215, 823.
15.
WorthleyL. I. G. (1974): “Lithium Toxicity and Refractory Cardiac Arrhythmia Treated with Intravenous Magnesium”, Anaesth. Intens. Care, 4, 357.
